Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

Thank you for registering

We are delighted to welcome you to this global group of researchers and clinicians.

You now have free, unrestricted access to the latest news, analysis and commentary about the rapidly evolving study of PCSK9 inhibition and its potential therapeutic importance in the prevention of premature CV death in millions of people with hypercholesterolaemia and accelerated atherosclerosis.

Please follow us on Twitter Please like us on Facebook

Continue browsing »